NCT03894215Phase 2Terminated

RaPiDS- A Phase 2 Study of Anti-PD-1 Independently or in Combination With Anti-CTLA-4 in Second-Line Cervical Cancer

Study sponsor: Agenus Inc. · AGEN

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2025-03-26Actual
Enrollment · participants211Actual
Source updated2026-03-27Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 5 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 212 participants (planned). After: 211 participants (actual).

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Aug 2025. After: 26 Mar 2025.

Recruitment status changed

Before: Active not recruiting. After: Terminated.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview